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Abstract
Background and Purpose: It is not known whether carbamazepine (CBZ; a drug widely used in
neurology and psychiatry) influences the blood oxygenation level dependent (BOLD) contrast
changes induced by neuronal activation and measured by functional MRI (fMRI). We aimed to
investigate the influence of CBZ on memory induced activation of the mesial temporal lobes in
patients with symptomatic temporal lobe epilepsy (TLE).
Material and Methods: Twenty-one individual patients with refractory symptomatic TLE with
different CBZ serum levels and 20 healthy controls were studied using BOLD fMRI. Mesial
temporal lobe (MTL) activation was induced by a task that is based on the retrieval of individually
familiar visuo-spatial knowledge. The extent of significant MTL fMRI activation was measured and
correlated with the CBZ serum level.
Results: In TLE patients, the extent of significant fMRI activation over both MTL was negatively
correlated to the CBZ serum level (Spearman r = -0.654, P < 0.001). Activation over the
supposedly normal MTL, i.e. contralateral to the seizure onset of TLE patients, was smaller than
the averaged MTL activation in healthy controls (P < 0.005). Age, duration of epilepsy, side of
seizure onset, and intelligence were not correlated to the extent of the significant BOLD-response
over both MTL in patients with TLE.
Conclusions: In TLE patients, carbamazepine reduces the fMRI-detectable changes within the
mesial temporal lobes as induced by effortful memory retrieval. FMRI appears to be suitable to
study the effects of chronic drug treatment in patients with epilepsy.
Introduction
Functional magnetic resonance imaging of the brain
(fMRI) is no longer exclusively used in normal control
subjects and highly selected patients, but increasingly
applied to large numbers of chronically ill patients in
clinical neurology and psychiatry [1]. In these settings,
fMRI is used to explore neuronal (dys-)function in or
close to brain regions implicated in the assumed disease
processes. Recently, fMRI has been applied to patients
with chronic epilepsy, mood disorders and chronic pain
without systematically exploring possible interactions
with pre-existing chronic medication [2–4].
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Carbamazepine (CBZ) is a widely used drug in neurology
and psychiatry. CBZ was originally introduced as an an-
ticonvulsant and nowadays is used as a first-line drug in
patients with localization-related epilepsies [5]. There is
good evidence that CBZ is effective in the management of
acute mania and prophylaxis of bipolar disorder, and it
might have some benefit in the treatment of drug-resist-
ant depression [6]. It is also used in patients with chronic
neuralgic facial pain and headaches [7]. The definite
modes of action remain unclear in these diverging man-
ifold CBZ usages, as do the causes for the cerebral side ef-
fects of the drug (drowsiness, vertigo etc.). There are only
single reports on CBZ affecting cerebral metabolism
measured with positron emission tomography (PET) [8].
There is no information whether the intravenous con-
centration of CBZ interferes with task-related contrast
changes of fMRI in patients treated chronically with
CBZ. Using a recently described memory fMRI paradigm
for single case studies we aimed to determine possible in-
teractions between CBZ serum levels and fMRI response
in mesial temporal lobe structures of patients with
chronic symptomatic temporal lobe epilepsy (TLE) [9].
Subjects and methods
Subjects
We studied 21 consecutive patients with refractory TLE
[11 women; mean age 35.7 years; SD 10.1; range 13 to 54
years) who underwent a comprehensive evaluation prior
to epilepsy surgery at our institution. All patients ful-
filled the following criteria: unilateral seizure onset of
temporal lobe origin shown by continuous interictal and
ictal video/EEG monitoring with scalp and sphenoidal
electrodes, and unilateral lesions within the temporal
lobes demonstrated by high resolution routine MRI. In
13 patients a right-sided and in eight patients a left-sided
TLE was diagnosed. Ten patients had hippocampal scle-
rosis, three vascular lesions, two tumors, and six miscel-
laneous or cryptogenic temporal lobe lesions. The mean
duration of epilepsy was 21.6 years (SD 9.4; range 1 to 35
years). Median seizure frequency was 3 complex partial
seizures/month (range 0.1–180 seizures/month). The
mean full scale IQ (WAIS-R, WCIS-R) was 96.3 (SD
20.6; range 51 to 126). Neither global nor selective cogni-
tive impairment were a criterion for patient exclusion.
All patients received CBZ (mean serum level 7.5 mg / l;
range 2.4 to 11.7). Two patients received gabapentine
(GBP: 3.8; 2.3 mg / l) and three patients lamotrigine
(LTG: 2.3; 3.2; 3.9 mg / l) as comedication.
Twenty healthy controls (10 women, mean age 31.7
years, SD 0.6) were also studied using fMRI.
FMRI task design
The paradigm consisted of 10 activation blocks and 10
baseline blocks. Each block was introduced by spoken
commands using the in-build communication device of
the commercially available MR scanner. The duration of
each block was 30 seconds. During each block, 10 sets of
16 coronal T2*-weighted MR-slices were obtained. Dur-
ing the activation block, retrieval from long-term memo-
ry without language was induced by self paced
performance of Roland's Hometown Walking task
[9,10]. The task were explained to the subjects in detail
before scanning. For each subject an individual home-
town walk encompassing ten destinations was prepared.
If a subject had recently moved, than the most familiar
hometown was chosen. The walk started either at home
or at a well known central point (e.g. place, station).
Then the subjects were asked to select a familiar land-
mark as destination. This landmark served as starting
point for the walk to the next destination. Subjects were
instructed to seek destinations within a 300 to 400 me-
ters range. After preparation of ten pairs of starting
points and destinations the complete route was present-
ed to the subject to ensure consistency and comprehen-
sion of the words denoting the route. During MR-
scanning, subjects were asked to mentally navigate
through the ten different routes and to imagine as many
details as possible while navigating. Subjects were in-
structed to look around the destination if they reach the
destination prior to the beginning of the baseline condi-
tion. After 30 seconds each route was interrupted by the
baseline task. The baseline condition consisted of covert-
ly counting odd numbers starting with 21. Children and
mentally impaired patients counted consecutively if they
had difficulties to count fluently odd numbers.
MRI acquisition
MRI scanning was performed on a 1.5 T scanner (Sie-
mens Magnetom Symphony, Erlangen, Germany)
equipped with a standard head coil. Scout and sagittal
T1-weighted images were obtained in every subject to po-
sition the coronal T2*-weighted images perpendicular to
the long axis of the hippocampus. For fMRI, 16 contigu-
ous coronal T2*-weighted images covering the temporal
lobes with a slice thickness of 5 mm were obtained using
a standard EPI sequence (TR = 1600 msec, TE = 50
msec, field of view 192 mm, matrix 64 ×  64).
Image analysis
Online image processing was performed using software
provided with the commercially available scanner which
recently has been compared to standard offline post-
processing software (SPM 99) [11]. The T2*-weighted
images were corrected for subject movement using an al-
gorithm for realignment in k-space. Images were
smoothed using a Gaussian filter (width 2.0) to prepareBMC Neurology 2001, 1:6 http://www.biomedcentral.com/1471-2377/1/6
statistical comparisons on a voxel-by-voxel basis. Voxel-
by-voxel z tests were performed for each subject, identi-
fying average signal intensity increases as measured dur-
ing the activation phases, compared to the average signal
intensity acquired during baseline conditions. The statis-
tical threshold was chosen to be z > 4, P < 0.00003 for a
single activated voxel. Statistical maps showing activated
voxels were projected onto EPI images of the same pa-
tient thus using images for display purposes with geo-
metric distortions similar to the fMRI data. To perform
group data analysis, two investigators blinded to clinical
data counted the numbers of voxels in a predefined re-
gion of interest over both MTL. The size of this region of
interest was 600 to 800 voxels per person. Counting
used the crus of the fornix as the posterior starting point
and continued anteriorly until no activated voxels were
found. Activated voxels were defined as those voxels that
had neighboring activated voxels, i.e. at least one adja-
cent activated voxel in plane and one neighboring acti-
vated voxel on at least one adjacent MR-slice. Clustering
removed small and scattered activated regions that were
unlikely to represent genuine brain activation. Cluster-
ing further reduced the real type I error probability of a z
> 4 threshold.
Statistical analysis
For each subject the absolute numbers of individual MTL
voxel counts were determined. In patients, activated vox-
els for the MTL ipsilateral and contralateral to the sei-
zure onset were counted. The total voxel number of both
MTL was summed up. Spearman's rank correlation coef-
ficients were computed between CBZ serum level, the ip-
silateral, contralateral, and total number of activated
voxels within MTL. A univariate analysis of variance
(ANOVA) was used to study effects of the factor 'side of
seizure onset' and of the covariates 'age', 'duration of ep-
ilepsy', and 'intelligence'. MTL activation contralateral to
the seizure onset of patients was compared to averaged
MTL activation of healthy controls using an univariate
ANOVA with study group as factor, while age served as
covariate. The influence of polytherapy and type of lesion
on the number of activated voxels was compared.
Results
Retrieval of hometown routes relative to the listing of
odd numbers resulted in significant T2*-contrast differ-
ences (z > 4) over regions within MTL of all subjects (Fig.
1). Activity was most frequently confined to the parahip-
pocampal gyrus. Clustered significant signal changes
projecting onto the hippocampus were not observed at
the statistical threshold chosen. Significant signal differ-
ences also were noted in several other areas, including
bilateral posterior-parietal cortex, retrosplenial cortex,
and mesial occipital cortex.
The CBZ serum level was negatively correlated with the
number of significantly activated MTL voxels: ipsilateral
r = -0.469, P < 0.05; contralateral r = -0.642, P < 0.002;
bilateral r = -0.654, P < 0.001). The CBZ epoxide serum
level did not further contribute to the explanation of var-
iance of the fMRI activation. There was no Spearman
rank correlation between seizure frequency and number
of activated voxels in the MTL opposite the seizure onset
(p > 0.1).
The analysis of variance on the number of bilaterally ac-
tivated MTL voxels revealed no effect of the factor side of
TLE (P > 0.2). The covariate CBZ serum level was related
to the number of activated voxels (F = 6.18, P < 0.05) but
not the variables age, duration of epilepsy, and intelli-
gence (P > 0.3). There was no difference in the number
of activated voxels between patients receiving exclusively
CBZ and patients with add-on medication. Patients with
hippocampal sclerosis showed less ipsilateral activation
compared with patients without hippocampal sclerosis
(P < 0.05).
The comparison of contralateral MTL activation of pa-
tients and averaged MTL activation of healthy controls
revealed less activation in patients (F = 10.33, P <
0.005). Age was unrelated to the number of activated
voxels.
Discussion
This is the first study correlating the spatial extent of sig-
nificant, mesiotemporal fMRI activation to intravenous
CBZ concentrations in patients with TLE. Thus, this
study adds to the ongoing discussion about the role of
fMRI in pharmacological research in neurology and psy-
chiatry [12,13]. Levels of antiepileptic drugs (AED) have
to be taken into account when interrogating fMRI stud-
ies for presurgical fMRI localization of memory [2,14,15]
and might even be important for the increasing clinical
use of fMRI in language lateralization, in localization of
motor function and seizure onset in patients with epilep-
sy [1,16].
Main advantage of fMRI is that the method has no
known biological side effect and uses no radioactive radi-
ation. Thus, it lends itself to pharmacological within-
subjects study designs which have been conducted with
fast acting compounds like acetazolamide, cocaine, nico-
tine, metamphetamine and diazepam [17–20]. Repeat-
ed, longitudinal studies of the effects of drug
administered over a longer interval [21] might be based
on cross-sectional data like the findings presented here.
In fMRI, the 'behavioral' measure of interest is a local-
ized T2*-contrast change due and close to neuronal acti-
vation. We are not drawing inferences about which partBMC Neurology 2001, 1:6 http://www.biomedcentral.com/1471-2377/1/6
Figure 1
Representative example of functional images of a 31-year-old female patient with left sided hippocampal sclerosis. Those voxels
whose signal intensity significantly increased (z > 4) in association with the visuo-spatial memory retrieval task are displayed in
white. Four consecutive slices of significant voxels superimposed on EPI images are shown. The right, contralateral MTL region
shows more significantly activated voxels than the left diseased MTL.BMC Neurology 2001, 1:6 http://www.biomedcentral.com/1471-2377/1/6
of the complex activation paradigm (imagery of visual
scenes, landmarks, navigation etc.) is responsible for the
mesiotemporal activation. The parahippocampal gyrus
underlying the activated voxels is nowadays accepted to
be active in response to landmarks and visual scenes of
depicted places [22,23]. The resulting bilateral mesio-
temporal activation in our experiment was shown rela-
tively homogeneously in all control subjects. In TLE
patients the extent of this significant contrast change
over both mesial temporal lobes was inversely correlated
to the CBZ drug level. The reduction of fMRI cluster size
was most marked, when the drug levels were close to tox-
ic levels. There is no behavioral data in our patient group
describing memory problems as a function of CBZ drug
levels – behavioral data, which by definition would have
to be of a longitudinal nature. Side effects like memory
decline depending on high CBZ drug levels, however,
have been described earlier [24].
The complex nature of task-related fMRI contrast chang-
es (from neuronal activation via neurovascular coupling
to T2*-contrast differences in active brain tissue [25]
leads to question the origin of the observed inverse cor-
relation between CBZ serum level and size of the cluster
of significantly activated voxels in mesiotemporal lobes
of TLE. It might be possible that CBZ related changes in
fMRI parallel reduced cerebral glucose metabolism as
shown by glucose PET in epilepsy patients receiving CBZ
[8], and thus represent neuronal dysfunction. To make
unspecific vascular effects unlikely, it might be necessary
to combine different methods in forthcoming longitudi-
nal studies (ideally covering initiation, chronic adminis-
tration and withdrawal of AED). Reduced cerebral
glucose metabolism has been observed using PET in dis-
eases with impairment of intellectual function [26]. In
our study there was no correlation between the extent of
significant mesiotemporal fMRI activation and a meas-
ure of global intellectual functioning like IQ. There is the
possibility that a high CBZ level is associated with a diffi-
cult-to-treat epilepsy. All our patients, however, were re-
fractory to medical treatment and there was no
correlation between the extent of mesiotemporal fMRI
activation and the current seizure frequency.
Conclusions
Pharmacological fMRI may prove useful for monitoring
cerebral changes following chronic administration of
AEDs. It might help to understand the profile of AED
side effects and, eventually, to identify individual pa-
tients prone to develop side effects.
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